These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 20658993)

  • 1. Deletion of murine tau gene increases tau aggregation in a human mutant tau transgenic mouse model.
    Ando K; Leroy K; Heraud C; Kabova A; Yilmaz Z; Authelet M; Suain V; De Decker R; Brion JP
    Biochem Soc Trans; 2010 Aug; 38(4):1001-5. PubMed ID: 20658993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Prion-like' propagation of mouse and human tau aggregates in an inducible mouse model of tauopathy.
    Sydow A; Mandelkow EM
    Neurodegener Dis; 2010; 7(1-3):28-31. PubMed ID: 20160454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated human mutant tau aggregation by knocking out murine tau in a transgenic mouse model.
    Ando K; Leroy K; Héraud C; Yilmaz Z; Authelet M; Suain V; De Decker R; Brion JP
    Am J Pathol; 2011 Feb; 178(2):803-16. PubMed ID: 21281813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation.
    Pérez M; Ribe E; Rubio A; Lim F; Morán MA; Ramos PG; Ferrer I; Isla MT; Avila J
    Neuroscience; 2005; 130(2):339-47. PubMed ID: 15664690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of tau pathology in tau transgenic models.
    Brion JP; Ando K; Heraud C; Leroy K
    Biochem Soc Trans; 2010 Aug; 38(4):996-1000. PubMed ID: 20658992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.
    Schindowski K; Bretteville A; Leroy K; Bégard S; Brion JP; Hamdane M; Buée L
    Am J Pathol; 2006 Aug; 169(2):599-616. PubMed ID: 16877359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load.
    Koson P; Zilka N; Kovac A; Kovacech B; Korenova M; Filipcik P; Novak M
    Eur J Neurosci; 2008 Jul; 28(2):239-46. PubMed ID: 18702695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice.
    Ishihara T; Zhang B; Higuchi M; Yoshiyama Y; Trojanowski JQ; Lee VM
    Am J Pathol; 2001 Feb; 158(2):555-62. PubMed ID: 11159192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau.
    Tatebayashi Y; Miyasaka T; Chui DH; Akagi T; Mishima K; Iwasaki K; Fujiwara M; Tanemura K; Murayama M; Ishiguro K; Planel E; Sato S; Hashikawa T; Takashima A
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13896-901. PubMed ID: 12368474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the cholinergic pathology in the P301L tau transgenic pR5 model of tauopathy.
    Köhler C; Bista P; Götz J; Schröder H
    Brain Res; 2010 Aug; 1347():111-24. PubMed ID: 20513372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies.
    Zilka N; Korenova M; Novak M
    Acta Neuropathol; 2009 Jul; 118(1):71-86. PubMed ID: 19238406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-amyloid treatment of two complementary P301L tau-expressing Alzheimer's disease models reveals similar deregulated cellular processes.
    David DC; Ittner LM; Gehrig P; Nergenau D; Shepherd C; Halliday G; Götz J
    Proteomics; 2006 Dec; 6(24):6566-77. PubMed ID: 17111439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model.
    Shiryaev N; Jouroukhin Y; Giladi E; Polyzoidou E; Grigoriadis NC; Rosenmann H; Gozes I
    Neurobiol Dis; 2009 May; 34(2):381-8. PubMed ID: 19264130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Filamin-A and Myosin VI colocalize with fibrillary Tau protein in Alzheimer's disease and FTDP-17 brains.
    Feuillette S; Deramecourt V; Laquerriere A; Duyckaerts C; Delisle MB; Maurage CA; Blum D; Buée L; Frébourg T; Campion D; Lecourtois M
    Brain Res; 2010 Jul; 1345():182-9. PubMed ID: 20460118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
    Zhang Q; Zhang X; Sun A
    Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raphé tauopathy alters serotonin metabolism and breathing activity in terminal Tau.P301L mice: possible implications for tauopathies and Alzheimer's disease.
    Menuet C; Borghgraef P; Matarazzo V; Gielis L; Lajard AM; Voituron N; Gestreau C; Dutschmann M; Van Leuven F; Hilaire G
    Respir Physiol Neurobiol; 2011 Sep; 178(2):290-303. PubMed ID: 21763469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of Tau at S422 is enhanced by Abeta in TauPS2APP triple transgenic mice.
    Grueninger F; Bohrmann B; Czech C; Ballard TM; Frey JR; Weidensteiner C; von Kienlin M; Ozmen L
    Neurobiol Dis; 2010 Feb; 37(2):294-306. PubMed ID: 19781645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
    Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
    Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced accumulation of tau in doubly transgenic mice expressing mutant betaAPP and presenilin-1.
    Samura E; Shoji M; Kawarabayashi T; Sasaki A; Matsubara E; Murakami T; Wuhua X; Tamura S; Ikeda M; Ishiguro K; Saido TC; Westaway D; St George Hyslop P; Harigaya Y; Abe K
    Brain Res; 2006 Jun; 1094(1):192-9. PubMed ID: 16713590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.